J05.0-1
DESCRIPTION
Croup is a common cause of potentially life-threatening airway obstruction in childhood. It is characterised by inflammation of the larynx, trachea and bronchi. Most common causative pathogens are viruses, including measles.
A clinical diagnosis of viral croup can be made if a previously healthy child develops progressive inspiratory airway obstruction with stridor and a barking cough, 1–2 days after the onset of an upper respiratory tract infection. A mild fever may be present.
Suspect foreign body aspiration if there is a sudden onset of stridor in an otherwise healthy child.
Suspect epiglottitis if the following are present in addition to stridor:
- very ill child
- drooling saliva
- high fever
- unable to swallow
- sitting upright with head held erect
Assessment of the severity of airway obstruction and management in croup
Grade 1 Inspiratory stridor only |
|
Grade 2 Inspiratory and expiratory stridor |
|
Grade 3 Inspiratory and expiratory stridor with active expiration, using abdominal muscles |
|
Grade 4 Cyanosis, apathy, marked retractions, impending apnoea |
|
GENERAL MEASURES
- Keep child comfortable.
- Continue oral fluids.
- Encourage parent or caregiver to remain with the child.
MEDICINE TREATMENT
- Paracetamol, oral, 10-15 mg/kg/dose 6 hourly when required. See paediatric dosing tool.
Children grade 2 or more stridor- while awaiting transfer:
- Adrenaline (epinephrine), 1:1000, nebulised, immediately using a nebuliser.
- If there is no improvement, repeat every 15 minutes, until the child is transferred.
- Dilute 1 mL of 1:1000 epinephrine (adrenaline) with 1 mL sodium chloride 0.9%.
- Nebulise the entire volume with oxygen at a flow rate of 6–8 L/minute.
- Corticosteroids (intermediate-acting) e.g.: LoEIII[26]
- Prednisone, oral, 1–2 mg/kg immediately as a single dose.
Weight kg |
Dose mg |
Tablet 5 mg |
Age months/years |
>11–14 kg | 20 mg | 4 tablets | >2–3 years |
>14–17.5 kg | 30 mg | 6 tablets | >3–5 years |
If epiglottitis suspected
- Ceftriaxone, IM, 80 mg/kg/dose immediately as a single dose and refer. See paediatric dosing tool.
- Do not inject more than 1 g at one injection site.
CAUTION: USE OF CEFTRIAXONE IN NEONATES AND CHILDREN
- If SUSPECTING SERIOUS BACTERIAL INFECTION in neonate, give ceftriaxone, even if jaundiced.
- Avoid giving calcium-containing IV fluids (e.g. Ringer Lactate) together with ceftriaxone:
- If ≤ 28 days old, avoid calcium-containing IV fluids for 48 hours after ceftriaxone administered.
- If > 28 days old, ceftriaxone and calcium-containing IV fluids may be given sequentially provided the giving set is flushed thoroughly with sodium chloride 0.9% before and after.
- Preferably administer IV fluids without calcium contents.
- Always include the dose and route of administration of ceftriaxone in the referral letter.
Management during transfer:
- Give the child oxygen.
- Continue nebulisations with epinephrine (adrenaline).
- If grade 3, contact ambulance or nearest doctor.
- If grade 4, intubate and transfer.
REFERRAL
Urgent
- Children with:
- chest indrawing
- rapid breathing
- altered consciousness
- inability to drink or feed
- For confirmation of diagnosis.
- Suspected foreign body.
- Suspected epiglottitis.
Non Urgent
- All children grade1 or 2 stridor.